• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023

    8/1/23 11:00:35 AM ET
    $AEO
    $APLS
    $BA
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEO alert in real time by email

    Upgrades

    According to Northcoast Research, the prior rating for Boeing Co (NYSE:BA) was changed from Sell to Neutral. In the second quarter, Boeing showed an EPS of $0.82, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $240.13 and a 52-week-low of $120.99. Boeing closed at $238.85 at the end of the last trading period.

    For Varonis Systems Inc (NASDAQ:VRNS), Craig-Hallum upgraded the previous rating of Hold to Buy. Varonis Systems earned $0.01 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Varonis Systems shows a 52-week-high of $32.05 and a 52-week-low of $15.61. Moreover, at the end of the last trading period, the closing price was at $28.70.

    Atlantic Equities upgraded the previous rating for The Goldman Sachs Group Inc (NYSE:GS) from Underweight to Neutral. For the second quarter, Goldman Sachs Gr had an EPS of $3.08, compared to year-ago quarter EPS of $7.73. The current stock performance of Goldman Sachs Gr shows a 52-week-high of $389.43 and a 52-week-low of $287.84. Moreover, at the end of the last trading period, the closing price was at $355.87.

    For ResMed Inc (NYSE:RMD), RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the third quarter, ResMed had an EPS of $1.68, compared to year-ago quarter EPS of $1.32. The current stock performance of ResMed shows a 52-week-high of $247.51 and a 52-week-low of $202.04. Moreover, at the end of the last trading period, the closing price was at $222.35.

    According to Barclays, the prior rating for Gap Inc (NYSE:GPS) was changed from Equal-Weight to Overweight. In the first quarter, Gap showed an EPS of $0.01, compared to $0.44 from the year-ago quarter. The current stock performance of Gap shows a 52-week-high of $15.49 and a 52-week-low of $7.22. Moreover, at the end of the last trading period, the closing price was at $10.30.

    According to Barclays, the prior rating for Tapestry Inc (NYSE:TPR) was changed from Equal-Weight to Overweight. For the third quarter, Tapestry had an EPS of $0.78, compared to year-ago quarter EPS of $0.51. The current stock performance of Tapestry shows a 52-week-high of $47.48 and a 52-week-low of $27.54. Moreover, at the end of the last trading period, the closing price was at $43.15.

    Barclays upgraded the previous rating for Bath & Body Works Inc (NYSE:BBWI) from Equal-Weight to Overweight. Bath & Body Works earned $0.33 in the first quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.55 and a 52-week-low of $30.52. Bath & Body Works closed at $37.06 at the end of the last trading period.

    For American Eagle Outfitters Inc (NYSE:AEO), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, American Eagle Outfitters showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. The current stock performance of American Eagle Outfitters shows a 52-week-high of $17.09 and a 52-week-low of $9.46. Moreover, at the end of the last trading period, the closing price was at $14.05.

    See all analyst ratings upgrades.

    Downgrades

    Argus Research downgraded the previous rating for Canadian National Railway Co (NYSE:CNI) from Buy to Hold. In the second quarter, Canadian National Railway showed an EPS of $1.31, compared to $1.51 from the year-ago quarter. The current stock performance of Canadian National Railway shows a 52-week-high of $129.85 and a 52-week-low of $103.81. Moreover, at the end of the last trading period, the closing price was at $121.23.

    According to RBC Capital, the prior rating for New Relic Inc (NYSE:NEWR) was changed from Outperform to Sector Perform. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. At the end of the last trading period, New Relic closed at $83.98.

    According to Hovde Group, the prior rating for Valley National Bancorp (NASDAQ:VLY) was changed from Outperform to Market Perform. For the second quarter, Valley Ntl had an EPS of $0.28, compared to year-ago quarter EPS of $0.32. The current stock performance of Valley Ntl shows a 52-week-high of $13.06 and a 52-week-low of $6.38. Moreover, at the end of the last trading period, the closing price was at $10.26.

    William Blair downgraded the previous rating for Symbotic Inc (NASDAQ:SYM) from Outperform to Market Perform. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.

    Citigroup downgraded the previous rating for Reata Pharmaceuticals Inc (NASDAQ:RETA) from Buy to Neutral. For the first quarter, Reata Pharmaceuticals had an EPS of $1.81, compared to year-ago quarter EPS of $1.33. At the moment, the stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. Reata Pharmaceuticals closed at $165.58 at the end of the last trading period.

    According to Loop Capital, the prior rating for MaxLinear Inc (NASDAQ:MXL) was changed from Buy to Hold. For the second quarter, MaxLinear had an EPS of $0.34, compared to year-ago quarter EPS of $1.11. The current stock performance of MaxLinear shows a 52-week-high of $43.66 and a 52-week-low of $22.25. Moreover, at the end of the last trading period, the closing price was at $24.67.

    According to DA Davidson, the prior rating for Symbotic Inc (NASDAQ:SYM) was changed from Buy to Neutral. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.

    For New Relic Inc (NYSE:NEWR), Baird downgraded the previous rating of Outperform to Neutral. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.

    According to Wells Fargo, the prior rating for Chinook Therapeutics Inc (NASDAQ:KDNY) was changed from Overweight to Equal-Weight. Chinook Therapeutics earned $0.85 in the first quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.54 and a 52-week-low of $17.72. Chinook Therapeutics closed at $39.18 at the end of the last trading period.

    According to Cantor Fitzgerald, the prior rating for Rivian Automotive Inc (NASDAQ:RIVN) was changed from Overweight to Neutral. Rivian Automotive earned $1.25 in the first quarter, compared to $1.43 in the year-ago quarter. The stock has a 52-week-high of $40.86 and a 52-week-low of $11.68. At the end of the last trading period, Rivian Automotive closed at $27.64.

    B of A Securities downgraded the previous rating for Apellis Pharmaceuticals Inc (NASDAQ:APLS) from Buy to Neutral. In the second quarter, Apellis Pharmaceuticals showed an EPS of $1.02, compared to $1.46 from the year-ago quarter. The current stock performance of Apellis Pharmaceuticals shows a 52-week-high of $94.75 and a 52-week-low of $24.97. Moreover, at the end of the last trading period, the closing price was at $25.75.

    Deutsche Bank downgraded the previous rating for ZoomInfo Technologies Inc (NASDAQ:ZI) from Buy to Hold. In the second quarter, ZoomInfo Technologies showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.85 and a 52-week-low of $20.33. ZoomInfo Technologies closed at $25.57 at the end of the last trading period.

    For New Relic Inc (NYSE:NEWR), Credit Suisse downgraded the previous rating of Outperform to Neutral. For the first quarter, New Relic had an EPS of $0.43, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.

    Citigroup downgraded the previous rating for The Estee Lauder Companies Inc (NYSE:EL) from Buy to Neutral. Estee Lauder Cos earned $0.47 in the third quarter, compared to $1.90 in the year-ago quarter. The stock has a 52-week-high of $284.27 and a 52-week-low of $171.93. At the end of the last trading period, Estee Lauder Cos closed at $180.00.

    According to Barclays, the prior rating for Reata Pharmaceuticals Inc (NASDAQ:RETA) was changed from Overweight to Equal-Weight. In the first quarter, Reata Pharmaceuticals showed an EPS of $1.81, compared to $1.33 from the year-ago quarter. The stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. At the end of the last trading period, Reata Pharmaceuticals closed at $165.58.

    Keefe, Bruyette & Woods downgraded the previous rating for SoFi Technologies Inc (NASDAQ:SOFI) from Market Perform to Underperform. In the second quarter, SoFi Techs showed an EPS of $0.06, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.70 and a 52-week-low of $4.25. SoFi Techs closed at $11.45 at the end of the last trading period.

    For Brown & Brown Inc (NYSE:BRO), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the second quarter, Brown & Brown showed an EPS of $0.68, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $72.99 and a 52-week-low of $52.82. At the end of the last trading period, Brown & Brown closed at $70.45.

    For Eastman Chemical Co (NYSE:EMN), Piper Sandler downgraded the previous rating of Overweight to Neutral. For the second quarter, Eastman Chemical had an EPS of $1.99, compared to year-ago quarter EPS of $2.83. At the moment, the stock has a 52-week-high of $102.12 and a 52-week-low of $69.91. Eastman Chemical closed at $85.58 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    RF Lafferty initiated coverage on Polestar Automotive Holding UK PLC (NASDAQ:PSNY) with a Buy rating. The price target for Polestar Automotive is set to $9.00. For the first quarter, Polestar Automotive had an EPS of $0.01, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $10.11 and a 52-week-low of $3.14. Polestar Automotive closed at $4.48 at the end of the last trading period.

    With an Overweight rating, Cantor Fitzgerald initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target seems to have been set at $16.00 for Health Catalyst. In the first quarter, Health Catalyst showed an EPS of $0.05, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $18.28 and a 52-week-low of $6.41. At the end of the last trading period, Health Catalyst closed at $14.03.

    Seaport Global initiated coverage on TopBuild Corp (NYSE:BLD) with a Buy rating. In the first quarter, TopBuild showed an EPS of $4.36, compared to $3.50 from the year-ago quarter. The current stock performance of TopBuild shows a 52-week-high of $280.67 and a 52-week-low of $140.93. Moreover, at the end of the last trading period, the closing price was at $273.93.

    For Installed Building Products Inc (NYSE:IBP), Seaport Global initiated coverage, by setting the current rating at Buy. Installed Building Prods earned $2.15 in the first quarter, compared to $1.54 in the year-ago quarter. The current stock performance of Installed Building Prods shows a 52-week-high of $150.88 and a 52-week-low of $75.45. Moreover, at the end of the last trading period, the closing price was at $148.02.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Vivid Seats Inc (NASDAQ:SEAT). The price target seems to have been set at $9.50 for Vivid Seats. Vivid Seats earned $0.15 in the first quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $9.89 and a 52-week-low of $6.29. At the end of the last trading period, Vivid Seats closed at $8.33.

    With a Buy rating, B. Riley Securities initiated coverage on Lilium NV (NASDAQ:LILM). The price target seems to have been set at $3.00 for Lilium. NoneThe stock has a 52-week-high of $3.25 and a 52-week-low of $0.37. At the end of the last trading period, Lilium closed at $1.37.

    See all analyst ratings initiations.

    Get the next $AEO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEO
    $APLS
    $BA
    $BBWI

    CompanyDatePrice TargetRatingAnalyst
    Installed Building Products Inc.
    $IBP
    2/11/2026Buy → Hold
    The Benchmark Company
    Estee Lauder Companies Inc.
    $EL
    2/10/2026$106.00Buy → Hold
    HSBC Securities
    SoFi Technologies Inc.
    $SOFI
    2/9/2026$30.00Mkt Perform → Mkt Outperform
    Citizens
    Estee Lauder Companies Inc.
    $EL
    2/6/2026$120.00Neutral → Buy
    Citigroup
    Tapestry Inc.
    $TPR
    2/6/2026$150.00 → $160.00Outperform
    Telsey Advisory Group
    Varonis Systems Inc.
    $VRNS
    2/5/2026$30.00Neutral → Buy
    DA Davidson
    SoFi Technologies Inc.
    $SOFI
    2/3/2026$31.00Neutral → Overweight
    Analyst
    SoFi Technologies Inc.
    $SOFI
    2/2/2026$36.00 → $33.00Buy
    Needham
    More analyst ratings

    $AEO
    $APLS
    $BA
    $BBWI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, President, Chairman Faitelson Yakov bought $598,907 worth of shares (26,725 units at $22.41), gifted 87,000 shares, received a gift of 78,928 shares and was granted 315,674 shares, increasing direct ownership by 14% to 2,098,387 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:31:52 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    EVP Engineering & CTO Bass David was granted 169,095 shares and bought $69,941 worth of shares (2,980 units at $23.47), increasing direct ownership by 20% to 1,042,924 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:27:11 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    Director Gavin John J Jr bought $112,700 worth of shares (5,000 units at $22.54), increasing direct ownership by 2% to 273,666 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:24:17 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    $AEO
    $APLS
    $BA
    $BBWI
    SEC Filings

    View All

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/11/26 3:39:40 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/11/26 1:55:33 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    SEC Form FWP filed by Goldman Sachs Group Inc.

    FWP - GOLDMAN SACHS GROUP INC (0000886982) (Subject)

    2/11/26 1:33:31 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AEO
    $APLS
    $BA
    $BBWI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEO
    $APLS
    $BA
    $BBWI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by General Counsel Lavet Robert S

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/11/26 7:46:42 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    CEO and Brand President, Coach Kahn Todd exercised 90,874 shares at a strike of $15.83, sold $6,025,599 worth of shares (39,815 units at $151.34) and covered exercise/tax liability with 51,059 shares (SEC Form 4)

    4 - TAPESTRY, INC. (0001116132) (Issuer)

    2/11/26 6:18:49 PM ET
    $TPR
    Apparel
    Consumer Discretionary

    Chief Financial Officer Coleman Denis P. sold $10,943,892 worth of shares (11,623 units at $941.57), decreasing direct ownership by 28% to 29,342 units (SEC Form 4)

    4 - GOLDMAN SACHS GROUP INC (0000886982) (Issuer)

    2/11/26 4:05:46 PM ET
    $GS
    Investment Bankers/Brokers/Service
    Finance

    $AEO
    $APLS
    $BA
    $BBWI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Installed Building Products downgraded by The Benchmark Company

    The Benchmark Company downgraded Installed Building Products from Buy to Hold

    2/11/26 6:57:04 AM ET
    $IBP
    Homebuilding
    Consumer Discretionary

    Estee Lauder downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Estee Lauder from Buy to Hold and set a new price target of $106.00

    2/10/26 7:59:21 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    SoFi Technologies upgraded by Citizens with a new price target

    Citizens upgraded SoFi Technologies from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    2/9/26 6:58:53 AM ET
    $SOFI
    Finance: Consumer Services
    Finance

    $AEO
    $APLS
    $BA
    $BBWI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Brown & Brown 2026 Market Trends Report sees softening commercial rates, more capacity, carrier competition

    DAYTONA BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) ("the Company") today announced the release of the 2026 edition of its Market Trends report. A comprehensive analysis of emerging market shifts, this year's report finds that rate conditions are shifting in favor of buyers who prepare thoroughly for the renewal process and have a positive claims history. The report also highlights industries and product lines where rate trends will remain firm and terms challenging. The first Market Trends report issued since the Company's 2025 acquisition of Risk Strategies offers a combination of deep knowledge and broad perspective from both organizations' specialists

    2/11/26 4:30:00 PM ET
    $BRO
    Specialty Insurers
    Finance

    AEO Inc. to Report Fourth Quarter and Full Year Fiscal 2025 Results on March 4, 2026

    American Eagle Outfitters, Inc. (NYSE:AEO) will report its fourth quarter and full year fiscal 2025 results by press release on Wednesday, March 4, 2026, after market close. At that time, a presentation of AEO's fourth quarter and full year fiscal 2025 results will be available on the company's website. The company will also host a summary of AEO Inc.'s fourth quarter and full year fiscal 2025 results with a live conference call that will be webcast on Wednesday, March 4, 2026, at 4:30 PM (ET). Webcast: To listen to the live webcast, click here. Replay: A replay will be available approximately 30 minutes following the event's conclusion at this link. The call will be archived and ma

    2/11/26 4:10:00 PM ET
    $AEO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Bath & Body Works Debuts Disney Princess Collection with New and Returning Fan-Favorite Fragrances

    What You Should Know: Bath & Body Works is launching its latest Disney Princess Collection at retail locations and online on February 13, 2026, featuring new and beloved fragrances inspired by the captivating stories of six Disney Princess characters: Aurora, Belle, Mulan, Rapunzel, Snow White, and Tiana, plus Life's a Fairytale fragrance.This collection offers consumers a variety of coveted fragrances and accessories across fine fragrance mist, body lotion, 3-wick candles and more.The international launch will follow starting in mid-March and reach more than 40 markets by the end of the year. COLUMBUS, Ohio, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works and Disney are back with a

    2/11/26 9:00:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AEO
    $APLS
    $BA
    $BBWI
    Financials

    Live finance-specific insights

    View All

    AEO Inc. to Report Fourth Quarter and Full Year Fiscal 2025 Results on March 4, 2026

    American Eagle Outfitters, Inc. (NYSE:AEO) will report its fourth quarter and full year fiscal 2025 results by press release on Wednesday, March 4, 2026, after market close. At that time, a presentation of AEO's fourth quarter and full year fiscal 2025 results will be available on the company's website. The company will also host a summary of AEO Inc.'s fourth quarter and full year fiscal 2025 results with a live conference call that will be webcast on Wednesday, March 4, 2026, at 4:30 PM (ET). Webcast: To listen to the live webcast, click here. Replay: A replay will be available approximately 30 minutes following the event's conclusion at this link. The call will be archived and ma

    2/11/26 4:10:00 PM ET
    $AEO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Presidio Announces Proposed $1 Billion Acquisition Financing Facility with Goldman Sachs

    Acquisition Facility expected to accelerate asset acquisition strategy Fort Worth, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) --   Presidio Investment Holdings LLC ("Presidio" or the "Company"), a differentiated oil and gas operator focused on the acquisition and optimization of mature, producing oil and natural gas assets in the United States, and EQV Ventures Acquisition Corp. (NYSE:FTW) ("FTW"), a special purpose acquisition company sponsored by EQV Group, today announced that Presidio has mandated an affiliate of Goldman Sachs (NYSE:GS) to arrange up to $1.0 billion  in potential acquisition financing for Presidio following the completion of its business combination. Goldman Sachs Bank USA

    2/10/26 8:00:00 AM ET
    $EQV
    $FTW
    $GS
    Oil & Gas Production
    Energy
    Investment Bankers/Brokers/Service
    Finance

    Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results

    WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the "Events and Presentations" page of the "Investors and Media" section of the company's website. A replay of the webcast will be available for 30 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company

    2/10/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEO
    $APLS
    $BA
    $BBWI
    Leadership Updates

    Live Leadership Updates

    View All

    Valley Bank Strengthens Leadership Team to Accelerate Partner Banking, Digital Innovation, and Customer Care

    New senior appointments advance Valley's growth strategy across fintech partnerships, digital channels, and relationship-driven banking Valley National Bank, a subsidiary of Valley National Bancorp (NASDAQ:VLY), today announced the appointment of three senior leaders: Rodrigo Suarez as Head of Partner Banking, Stephen Schroth as the Head of Digital & Assisted Channels, and Ed Montesdeoca to lead Customer Care & Strategy. Together, these appointments underscore Valley's continued investment in innovation, customer experience and digital transformation. Partner Banking is a key component of Valley's long-term growth strategy, enabling the Bank to collaborate with fintechs, technology plat

    2/11/26 8:00:00 AM ET
    $VLY
    Major Banks
    Finance

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    Delta Air Lines Orders up to 60 Boeing 787 Dreamliners to Grow, Modernize Widebody Fleet

    Global carrier orders 787-10 airplanes for international expansionUltra-efficient, spacious widebody jets will also support fleet modernizationLatest purchase brings Delta's order book to 130 Boeing airplanes as it builds future fleetSEATTLE, Jan. 13, 2026 /PRNewswire/ -- Boeing (NYSE:BA) and Delta Air Lines today announced the U.S. carrier placed its first direct order for up to 60 787 Dreamliners to support long-haul international growth and renew the airline's widebody fleet. Delta's purchase of 30 787-10 jets – with opportunity for up to 30 more of the largest 787 variant – will enable the airline's expansion and modernization plans on high-demand transatlantic and South American routes.

    1/13/26 7:02:00 AM ET
    $BA
    Aerospace
    Industrials

    $AEO
    $APLS
    $BA
    $BBWI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:28 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary